Vitamin D Deficiency
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Volunteers followed at the clinic with a diagnosis of Cystic Fibrosis; both genders; over 5 years of age; clinically stable; no use of vitamin D megadose
Exclusion criteria
Exclusion criteria: Patients with kidney or liver failure; patients on the waiting list for lung or kidney transplantation; who did not accept to participate in the research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected to find an increase in 25(OH)D levels after the intervention;Different responses to supplementation according to genotypes of the BsmI polymorphism of the VDR gene | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected that after supplementation, there will be a reduction in inflammatory process and oxidative stress markers | — |
Countries
Brazil